Dimethyl ether (DME) is a synthetically produced alternative fuel to diesel-based and could be used in ignition diesel engines due increasing energy demand. DME considered extremely clean transportation green because it has high cetane number (around 60), low boiling point (−25 °C), oxygen amount (35 wt%) which allow fast evaporation higher combustion quality (smoke-free operation 90% fewer NOx...

Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population. However, there is limited understanding of the epidemiology of DME with visual impairment (VI) and treatment in patients with diabetes in Canada. This observational, retrospective study used records from the Southwestern Ontario database to observe the demographics, prevalence, and treatment characteristi...

diabetic macular edema (dme) is an important cause of blindness in the working population and is currently challenging to treat. current interventions include focal laser or intravitreal injections. this article outlines a new treatment protocol based on the concept that peripheral ischemia is the introduction to angiogenesis, that will ultimately gather its momentum at the fovea. performing ex...

Distributed mutual-exclusion (DME) circuits are an interesting example of asynchronous circuits. They are composed of identical DME cells connected in a ring of arbitrary size. Each DME cell provides a connection point for one user, and all users compete for exclusive access to a shared resource. This paper reports about formal verification of two well-known DME circuit implementations. Externa...

The ignition temperature of nitrogen-diluted dimethyl ether (DME) by heated air in counterflow was experimentally determined for DME concentration from 5.9% to 30%, system pressure from 1.5 to 3.0 atm, and pressure-weighted strain rate from 110 to 170 s . These experimental data were compared with two mechanisms that were, respectively, available in 1998 and 2003, with the latter being a substa...

macular edema following diabetic retinopathy is one of the ocular complications associated with diabetes, and it is the leading cause of visual loss in the active young and middle aged population in developed countries. while all patients with diabetes particularly those with diabetic retinopathy are at increased risk of developing eye complications, early detection and timely intervention may ...

Purpose To investigate the association between hyperreflective dots (HRDs) on spectral-domain optical coherence tomography (SD-OCT) and response to intravitreal bevacizumab (IVB) or dexamethasone injection in eyes with diabetic macular edema (DME) or macular edema due to retinal vein occlusion (RVO). Methods A retrospective review was conducted involving patients with DME or macular edema due...

INTRODUCTION The pathophysiology of diabetic macular edema (DME) is complex, involving vascular endothelial growth factor (VEGF) and other inflammatory mediators. DME is currently treated first-line with intravitreal anti-VEGF treatments, though some cases are refractory to multiple anti-VEGF treatments. AREAS COVERED This article examines the evolution of treatment practices for DME, with di...